| 摘要 |
The present invention relates to a pharmaceutical composition or health functional food comprising cathayanin B or kuwanol A, which are compounds isolated from morus bark, for preventing and treating diabetic complications. According to the present invention, the cathayanin B compound is isolated from the morus bark, and inhibits the creation of an advanced glycation end-product (AGE), which is a causative substance of diabetic complications, and aldose reductase activity. Thus, the pharmaceutical composition or health functional food, which comprises the cathayanin B or the kuwanol A, can be useful for inhibiting diabetic complications such as diabetic nephropathy, diabetic retinopathy and diabetic neuropathy. In particular, the kuwanol A can be used as the pharmaceutical composition for preventing and treating various fibrosis and cancer metastasis as well as the diabetic complications and also used as the health functional food for alleviating the same. |
